Article Text
Abstract
Objective To assess parental permission for a neonate's research participation using the MacArthur competence assessment tool for clinical research (MacCAT-CR), specifically testing the components of understanding, appreciation, reasoning and choice.
Study Design Quantitative interviews using study-specific MacCAT-CR tools.
Hypothesis Parents of critically ill newborns would produce comparable MacCAT-CR scores to healthy adult controls despite the emotional stress of an infant with critical heart disease or the urgency of surgery. Parents of infants diagnosed prenatally would have higher MacCAT-CR scores than parents of infants diagnosed postnatally. There would be no difference in MacCAT-CR scores between parents with respect to gender or whether they did or did not permit research participation.
Participants Parents of neonates undergoing cardiac surgery who had made decisions about research participation before their neonate's surgery.
Methods The MacCAT-CR.
Results 35 parents (18 mothers; 17 fathers) of 24 neonates completed 55 interviews for one or more of three studies. Total scores: magnetic resonance imaging (mean 36.6, SD 7.71), genetics (mean 38.8, SD 3.44), heart rate variability (mean 37.7, SD 3.30). Parents generally scored higher than published subject populations and were comparable to published control populations with some exceptions.
Conclusions The MacCAT-CR can be used to assess parental permission for neonatal research participation. Despite the stress of a critically ill neonate requiring surgery, parents were able to understand study-specific information and make informed decisions to permit their neonate's participation.
- informed consent
- MacArthur competence assessment tool for clinical research
- newborns and minors
- research ethics
- research on special populations
- understanding
Statistics from Altmetric.com
Footnotes
Funding Supported in part by a grant from the Florence RC Murray Program of the Joseph Stokes, Jr Research Institute of The Children's Hospital of Philadelphia.
Competing interests None.
Disclaimer The work reported in this article was performed prior to RMN joining the Food and Drug Administration. The opinions expressed herein do not represent the views of the Food and Drug Administration nor the Department of Health and Human Services.
Ethics approval This study was approved by the Children's Hospital of Philadelphia Institutional Review Board.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
Linked Articles
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Low risk of necrotising enterocolitis in enterally fed neonates with critical heart disease: an observational study
- What factors are important to parents making decisions about neonatal research?
- Outcomes of neonatal critical congenital heart disease: results of a prospective registry-based study from South India
- Neonatal screening for life threatening congenital heart disease
- Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39 821 newborns
- Uncertainty associated with parents of preterm infants hospitalised in neonatal intensive care unit among selected governmental hospitals in Addis Ababa, Ethiopia, 2022: an institution-based cross-sectional study
- Heart rate variability in bipolar disorder and borderline personality disorder: a clinical review
- Clinicians’ criteria for fetal moral status: viability and relationality, not sentience
- Neonatal heart rate variability: a contemporary scoping review of analysis methods and clinical applications
- 2020 Western Medical Research Conference